These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7107073)

  • 1. New physiologically based methods for calculating the apparent steady-state volume of distribution in pharmacokinetic studies.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):255-8. PubMed ID: 7107073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The physiological significance of the apparent volume of distribution, Vdarea or Vd beta, in pharmacokinetic studies.
    Chiou WL
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):499-508. PubMed ID: 7330454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical comparison between volume of distribution (V) and volume of distribution at steady-state (Vss) utilizing model-independent approach.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2004 Mar; 25(2):99-101. PubMed ID: 14872558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of drug dosage regimens with a pharmacokinetic slide rule.
    Straughn AB; Cruze CA; Meyer MC
    Am J Hosp Pharm; 1977 Feb; 34(2):197-200. PubMed ID: 842548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is volume of distribution at steady state a meaningful kinetic variable?
    Greenblatt DJ; Abernethy DR; Divoll M
    J Clin Pharmacol; 1983; 23(8-9):391-400. PubMed ID: 6355205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part I).
    Chiou WL
    Clin Pharmacokinet; 1989 Sep; 17(3):175-99. PubMed ID: 2680213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the accuracy of calculation of the mean residence time of drug in the body and its volumes of distribution based on the assumption of central elimination.
    Berezhkovskiy LM
    Xenobiotica; 2016; 46(6):477-82. PubMed ID: 26406808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arterial and venous blood sampling in pharmacokinetic studies: propranolol in rabbits and dogs.
    Lam G; Chiou WL
    Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):33-48. PubMed ID: 7268207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs.
    De Buck SS; Sinha VK; Fenu LA; Nijsen MJ; Mackie CE; Gilissen RA
    Drug Metab Dispos; 2007 Oct; 35(10):1766-80. PubMed ID: 17620347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically based approaches towards the prediction of pharmacokinetics: in vitro-in vivo extrapolation.
    De Buck SS; Mackie CE
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):865-78. PubMed ID: 18028030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steady-state volume of distribution and dilution factor.
    Bocchialini BM
    Arzneimittelforschung; 1994 Apr; 44(4):571-5. PubMed ID: 8011015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.
    Liu J; Kraut EH; Balcerzak S; Grever M; D'Ambrosio S; Chan KK
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):445-53. PubMed ID: 12451470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steady-state solutions to PBPK models and their applications to risk assessment I: Route-to-route extrapolation of volatile chemicals.
    Chiu WA; White P
    Risk Anal; 2006 Jun; 26(3):769-80. PubMed ID: 16834633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of the arterial-venous plasma concentration difference in clearance studies.
    Chiou WL; Lam G
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):197-203. PubMed ID: 7095918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of arterial-venous plasma concentration differences on the determination of mean residence time of drugs in the body.
    Chiou WL; Lam G; Chen ML; Lee MG
    Res Commun Chem Pathol Pharmacol; 1982 Jan; 35(1):17-26. PubMed ID: 7058288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery.
    Lüpfert C; Reichel A
    Chem Biodivers; 2005 Nov; 2(11):1462-86. PubMed ID: 17191947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of midazolam in man (author's transl)].
    Lauven PM; Stoeckel H; Ochs H; Greenblatt DJ
    Anaesthesist; 1981 Jun; 30(6):280-3. PubMed ID: 7270857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Pharmacokinetic Approach for a Better Understanding of the Relationship Between the Terminal Half-Life of Drug and Its Physiologically Based Pharmacokinetic Parameters.
    Kwon Y
    J Pharm Sci; 2020 Mar; 109(3):1421-1423. PubMed ID: 31863732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial and venous blood sampling in pharmacokinetic studies: bumetanide in rabbits.
    Chung SY; Yoon WH; Kim SH; Hwang KS; Lee MG
    Res Commun Mol Pathol Pharmacol; 1997 Dec; 98(3):255-64. PubMed ID: 9485520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical analysis of the discrepancy between V(beta) and V(ss) for drugs exhibiting different two-compartment disposition profiles.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2005 Mar; 26(2):51-8. PubMed ID: 15614832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.